Skip to main content
Equibles

WELLS FARGO & COMPANY/MN

Position in QURE — uniQure N.V.

CIK 72971 SAN FRANCISCO, CA
Back to QURE Full portfolio

Position in QURE

as of Jun 30, 2026 · filed Aug 14, 2026
Position Value
$6,907,663
+$5,216,322 QoQ
Shares Held
149,971
+45.0% QoQ
Ownership
0.238%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#67
of 255 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority Sole 93% Shared 0% None 7%

Common Shares in QURE Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

WELLS FARGO & COMPANY/MN holds $1,575,562,942 across 417 Biotechnology names. QURE ranks #42 (0.4% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 VRTX
Vertex Pharmaceuticals Inc / Ma
 749,528 $372,313,040
2 HALO
Halozyme Therapeutics, Inc.
 1,390,428 $108,828,797
3 ALNY
Alnylam Pharmaceuticals, Inc.
 310,047 $93,333,446
4 REGN
Regeneron Pharmaceuticals, Inc.
 140,802 $87,795,677
5 EXEL
Exelixis, Inc.
 717,840 $39,057,673
6 RVMD
Revolution Medicines, Inc.
 178,780 $33,481,916
7 ARGX
Argenx SE
 34,453 $31,964,458
8 INCY
Incyte Corp
 255,064 $28,914,053

All Filings in QURE

Export CSV
26 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $6,907,663 149,971
2026-03-31 $1,691,341 103,446
2025-12-31 $1,680,746 70,236
2025-09-30 $632,905 10,843
2025-06-30 $152,531 10,942
2025-03-31 $130,698 12,330
2024-12-31 $217,112 12,294
2024-09-30 $53,199 10,791
2024-06-30 $48,634 10,856
2024-03-31 $58,276 11,207
2023-12-31 $61,450 9,077
2023-09-30 $613,146 91,378
2023-06-30 $587,462 51,262
2023-03-31 $1,021,399 50,715
2022-12-31 $287,295 12,673
2022-09-30 $305,317 16,275
2022-06-30 $403,945 21,671
2022-03-31 $363,097 20,094
2021-12-31 $313,525 15,117
2021-09-30 $6,113,364 190,983
2021-06-30 $569,183 18,480
2021-03-31 $623,465 18,506
2020-12-31 $1,453,833 40,239
2020-09-30 $1,165,926 31,657
2020-06-30 $1,327,105 29,452
2020-03-31 $1,584,353 33,390